SCHEMBL6840528

SCHEMBL6840528

CC(O)Sc1ccc(C(=O)O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.58
TSHR P16473 3/20 0.50
TP53 P04637 1/20 0.50
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
SRD5A2 P31213 2/20 0.44
CA1 P00915 4/20 0.43
CA2 P00918 4/20 0.43
CA12 O43570 2/20 0.43
CA3 P07451 2/20 0.43
CA6 P23280 2/20 0.43
CA5A P35218 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
CA14 Q9ULX7 2/20 0.43
CA5B Q9Y2D0 2/20 0.43
TYR P14679 1/20 0.43
DRD1 P21728 1/20 0.43
CA4 P22748 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1021140 0.85 HTT (0.59) HTTTSHRTP53KMT2AALDH1A1
Terephthalic Acid SCHEMBL28509987 0.79 TSHR (0.71) TSHRTP53KMT2AALDH1A1SMN1; SMN2
Terephthalic Acid SCHEMBL338413 0.79 TSHR (0.71) TSHRTP53KMT2AALDH1A1SMN1; SMN2
Terephthalic Acid SCHEMBL4243136 0.79 TSHR (0.71) TSHRTP53KMT2AALDH1A1SMN1; SMN2
SCHEMBL6476384 0.79 HTT (0.67) HTTTSHRTP53KMT2AALDH1A1
SCHEMBL3465503 0.77 HTT (0.56) HTTTSHRTP53KMT2AALDH1A1
Terephthalic Acid SCHEMBL27832014 0.77 TSHR (0.67) TSHRTP53KMT2AALDH1A1SMN1; SMN2
SCHEMBL9018820 0.77 HTT (0.55) HTTTSHRTP53ALDH1A1SMN1; SMN2
SCHEMBL2283560 0.77 HTT (0.55) HTTTSHRTP53KMT2AALDH1A1
Terephthalic Acid SCHEMBL23071346 0.77 TSHR (0.75) TSHRTP53KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040171079-A1 Combinatorial active compound synthesis and its intermediates HAAF KLAUS (DE) 2004-09-02 US disclosed
US-20030158443-A1 Combinatorial active compound synthesis and its intermediates HAAF KLAUS (DE) 2003-08-21 US disclosed
EP-0837056-B1 Combinatorial reagent synthesis and intermediates therefor BAYER CROPSCIENCE GMBH (DE) 2003-01-08 EP disclosed
US-20020128383-A1 COMBINATORIAL ACTIVE COMPOUND SYNTHESIS AND ITS INTERMEDIATES HOECHST SCHERING AGREVO GMBH (DE) 2002-09-12 US disclosed
EP-0837056-A2 Combinatorial reagent synthesis and intermediates therefor Hoechst Schering AgrEvo GmbH (DE) 1998-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171079-A1 Combinatorial active compound synthesis and its intermediates NCL, POLR2E, NOC2L HTT 2081/4885TSHR 3718/4885TP53 4491/4885
US-20030158443-A1 Combinatorial active compound synthesis and its intermediates NCL, POLR2E, COASY HTT 2072/4885TSHR 3823/4885TP53 4528/4885
US-20020128383-A1 COMBINATORIAL ACTIVE COMPOUND SYNTHESIS AND ITS INTERMEDIATES NCL, POLR2E, NOC2L HTT 2055/4885TSHR 3781/4885TP53 4463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.